We purified a novel angiotensin-I converting enzyme (ACE) inhibitor from fish sauce Ishiru prepared from squid, and identified it as the tripeptide Leu-Ala-Arg (LAR). IC 50 of this ACE inhibitor was 2.5 µM, demonstrating high potency among peptides previously purified from fish sauces. Moreover, LAR acted as an antihypertensive peptide, reducing systolic blood pressure in spontaneously hypertensive rats.
INTRODUCTION
Fish sauce is an ancient seasoning that is produced and used worldwide. At present, it is produced and consumed mainly in Southeast Asia, particularly in nam-pla of Thailand, nuoc-mam of Vietnam, and patis in the Philippines. Although it is not a major sauce, fish sauce is also produced in Japan and is used as a seasoning for various processed foods. Ishiru is a representative fish sauce in Japan and is traditionally produced in the peninsula area of Ishikawa prefecture. Ishiru is mainly prepared from squid or sardine, and fish sauce prepared from squid in particular is unique in the world. We previously reported that Ishiru contains large quantities of peptides and free amino acids, and it has strong health-promoting properties, including angiotensin-I converting enzyme (ACE) inhibitory and antioxidant activities.
1,2)
ACE inhibitory activity is an important function of food because this activity produces a drop in blood pressure and relief from hypertension. Substances that inhibit ACE prevent production of the potent vasoconstrictor angiotensin-II from angiotensin-I. 3, 4) Hypertension causes cardiovascular diseases, renal disease, and stroke. 5) Thus, ACE inhibitors are used in the treatment of essential hypertension and cardiac failure in humans. However, they are believed to cause a number of side effects such as cough, skin rashes, and angioedema. 6,7) Many researchers have purified and identified ACE inhibitory peptides from enzymatic digests of various proteins from food such as fish [8] [9] [10] [11] [12] , meat 13, 14) supplements for hypertension 20) . Fish sauce is expected to con- , and oyster 24) , whereas no such ACE inhibitory peptides have been isolated from fish sauce prepared from squid. Thus, we aimed to isolate a new and strong ACE inhibitory substance from Ishiru prepared from squid, paying special attention to lowmolecular-weight peptides because such peptides are readily absorbed in the body. In this study, we isolated and purified a ACE inhibitory peptide from Ishiru and investigated the antihypertensive action of this peptide by administering it orally to spontaneously hypertensive rats (SHRs).
MATERIALS AND METHODS
The Ishiru prepare from squid was purchased from a local The tail-cuff method was used to measure SBP using a sphygmomanometer (BP-98A; Softron Corp., Tokyo, Japan). Differences in SBP before and after administration were analyzed using the Student's t-test.
RESULTS AND DISCUSSION
An ACE inhibitory peptide was purified from Ishiru by acetonitrile extraction, dialysis, and ultrafiltration. The filtrate was applied to a Sephadex LH-20 column, and the chromatogram is shown in Fig. 1a . Fraction 48 exhibited the strongest ACE inhibitory activity. Poor correspondence of peak ACE inhibitory activity and absorbance at 280 nm indicated the absence of aromatic groups in the ACE inhibitory substance.
Fraction 48 was lyophilized and applied to a C 18 column. As shown in Fig. 1b , there were four major absorbance peaks at 216 nm. Fractions eluted at 38 min exhibited strong activity (82% inhibition) and were pooled and lyophilized immediately.
The weight of the resulting powder was approximately 3 mg.
The amino acid sequence of the purified peptide was determined to be Leu-Ala-Arg (LAR), which has never been reported as an ACE inhibitory peptide. By searching the amino acid sequence of LAR in previous reports, it was found that LAR exists in major lens proteins of squid 28) . Squid eyeballs are one of the ingredients of Ishiru. Hence, LAR derived from major lens proteins might be found in Ishiru. IC 50 of LAR was determined to be 2.5 μM and that of peptides purified from other fish sauces 21-24) was reported to be 1.8-147 μM. Hence, the ACE inhibitory activity of LAR is high among peptides previously purified from fish sauce.
We isolated the peptide LAR showing strong ACE inhibitory activity from Ishiru and then investigated the antihypertensive action of the synthetic peptide with the same structure as LAR by administering it orally to SHRs. Fig. 2 shows the change in SBP after oral administration of the ACE inhibitor in SHRs.
The antihypertensive activity of LAR was evaluated in comparison to that of VY (a positive control). It is well known that VY, which was purified from sardine hydrolysates by protease digestion, exhibits strong ACE inhibitory activity in SHRs.
8)
SBP in LAR-treated SHRs was reduced from 4 h to 12 h after administration. It is expected that LAR, as a small peptide (dior tri-peptide), is easily absorbed in its intact form in the intestine and then exhibits a strong suppressive effect on SBP in SHRs. On the other hand, a reduction in SBP in VY-treated SHRs was only observed at 4 h. Therefore, the antihypertensive activity of LAR was found to be higher than that of VY.
This result suggests the promising application of LAR as an antihypertensive functional food. Moreover, consumption of Ishiru may help to maintain blood pressure within the normal range. Our future focus will be to evaluate the blood pressurelowering effect of LAR in human clinical trials. 
